Belay Diagnostics Appoints Stanford Neuro-Oncologist Seema Nagpal as Chief Medical Officer
Belay Diagnostics has appointed Dr. Seema Nagpal, a board-certified neuro-oncologist from Stanford University, as its first Chief Medical Officer effective November 19, 2026. The Chicago-based molecular diagnostics company specializes in cerebrospinal fluid (CSF) liquid biopsy testing for central nervous system (CNS) cancers. Dr. Nagpal will oversee the company's clinical strategy, research initiatives, and physician engagement efforts. She is also tasked with leading the development of an interactive molecular case review platform to assist clinicians in managing complex neuro-oncology cases using Belay's proprietary testing technology.
Topics: Chief Medical Officer CNS Cancer Executive Hire Molecular Diagnostics